Table 1 Incidence of cardiovascular disease, death, and composite outcome in the KNOW-CKD cohort.

From: Incidence of cardiovascular events and mortality in Korean patients with chronic kidney disease

 

Total (n = 2179)

Diabetes (n = 728)

Non-diabetes (n = 1451)

P-value

CKD stage G1-G2 (n = 767)

CKD stage G3a-G5 (n = 1412)

P-value

Event number

Incidencea

Event number

Incidencea

Event number

Incidencea

Event number

Incidencea

Event number

Incidencea

Composite outcome

208

24.5

107

41.5

101

17.0

 < 0.001

42

13.5

166

30.7

 < 0.001

Death

84

9.6

45

16.6

39

6.4

 < 0.001

9

2.8

75

13.3

 < 0.001

Cardiovascular disease

146

17.2

77

29.7

69

11.6

 < 0.001

34

11.0

112

20.6

0.001

Coronary artery disease

72

8.4

44

17.0

28

4.7

 < 0.001

12

3.9

60

11.0

0.001

Ischemic stroke

24

2.8

15

5.8

9

1.5

0.001

6

1.9

18

3.3

0.254

Congestive heart failure

5

0.6

4

1.5

1

0.2

0.047

1

0.3

4

0.7

0.460

Cerebral hemorrhage

9

1.1

4

1.5

5

0.8

0.366

5

1.6

4

0.7

0.242

Others

36

4.2

10

3.9

26

4.4

0.736

10

3.2

26

4.8

0.289

Follow up time (person-year)

8794.4

2718.1

6076.3

 

3176.2

5618.1

 
  1. P-value from Poisson regression model in the incidence comparisons of diabetes vs. non-diabetes and CKD stages G1–G2 vs. CKD stages G3a–G5.
  2. CKD chronic kidney disease.
  3. aIncidence per 1000 person-years.